MedTrace Logo

Dimensional Changes of Peri-implant Tissues Following Jumping Gap Grafting Using Erythropoietin Gel Mixed With Xenograft.

NCT07523412 · Status: NOT_YET_RECRUITING · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 26

Last updated 2026-04-15

No results posted yet for this study

Summary

This study will be conducted to compare the effect of Erythropoietin gel mixed with xenograft versus xenograft alone in grafting the jumping gap around immediate implant.

Conditions

  • Peri-implant Bone and Soft Tissues

Interventions

DRUG

Erythropoetin gel mixed with xenogenic bone graft

Patients with EPO gel mixed with xenogenic bone graft in the jumping gap of immediate implant.

OTHER

Xenogenic bone with gelling aget CMC ( carboxymethyl cellulose)

Patients with xenogenic bone graft and gelling agent in the jumping gap of immediate implant.

Sponsors & Collaborators

  • Ain Shams University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-04-12
Primary Completion
2026-10-12
Completion
2026-11-12
FDA Drug
Yes

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07523412 on ClinicalTrials.gov